Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction – Full Text View – ClinicalTrials.gov
Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction – Full Text View – ClinicalTrials.gov
BREAKING NEWS
Reven Announces Coronavirus Treatment Acceleration Program (CTAP) Submission to the FDA
FOR IMMEDIATE RELEASE Reven Announces Coronavirus Treatment Acceleration Program (CTAP) Submission to the FDA Golden, Colorado, Friday, April 3, 2020 [...]
2020/03/28 Reven News Press
A Phase 1, Double-blind, Placebo-controlled, Randomized, Two-Part, Ascending Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Rejuveinix [...]
2020/03/23 Reven News Press
Reven successfully completes Phase I clinical trials and is pleased to announce completion with no Serious Adverse Events and no [...]
In 2019, Reven completed their single-ascending-dose (SAD)/multiple-ascending-dose(MAD) Phase 1 Clinical Trial in the United States. Reven is now in the planning stage of their Phase 2 Clinical Trial that will be conducted in the United States in Q2/Q3 of 2020.